Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

JK AGRI GENETICS LTD.

NSE : NABSE : 536493ISIN CODE : INE690O01011Industry : AgricultureHouse : Private

BSE336.15-2.8 (-0.83 %)

PREV CLOSE ( ) 338.95

OPEN PRICE ( ) 338.95

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 275

TODAY'S LOW / HIGH ( )325.10 342.95

52 WK LOW / HIGH ( ) 312649

NSE

This Company is not listed in NSE

Select year

Particulars

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Mar 2020

Operational & Financial Ratios

Earnings Per Share (Rs)

-44.90

-23.29

16.67

15.46

-25.90

CEPS(Rs)

-37.43

-17.99

24.09

23.07

-16.89

DPS(Rs)

0.00

1.50

0.00

Book NAV/Share(Rs)

237.29

281.74

306.32

291.92

252.71

Tax Rate(%)

29.68

29.31

24.61

28.42

34.14

Margin Ratios

Core EBITDA Margin(%)

-17.20

-4.17

5.55

9.03

-2.41

EBIT Margin(%)

-14.50

-4.11

6.43

7.36

-4.19

Pre Tax Margin(%)

-19.99

-7.60

4.17

4.48

-9.08

PAT Margin (%)

-14.06

-5.37

3.14

3.20

-5.98

Cash Profit Margin (%)

-11.72

-4.15

4.54

4.78

-3.90

Performance Ratios

ROA(%)

-6.50

-3.12

2.30

2.56

-4.34

ROE(%)

-17.30

-7.92

5.57

5.97

-11.07

ROCE(%)

-13.91

-4.81

9.54

10.73

-5.15

Asset Turnover(x)

0.46

0.58

0.73

0.80

0.73

Sales/Fixed Asset(x)

2.92

4.20

5.20

4.79

4.09

Working Capital/Sales(x)

3.39

2.39

2.21

2.36

2.41

Efficiency Ratios

Fixed Capital/Sales(x)

0.34

0.24

0.19

0.21

0.24

Receivable days

150.41

157.52

133.93

115.44

139.62

Inventory Days

299.62

248.41

193.55

183.04

234.32

Payable days

372.87

362.88

319.50

247.41

234.18

Valuation Parameters

PER(x)

0.00

36.37

34.75

0.00

PCE(x)

-9.76

-21.05

25.18

23.29

-20.12

Price/Book(x)

1.54

1.34

1.98

1.84

1.34

Yield(%)

0.00

0.25

0.28

0.00

EV/Net Sales(x)

1.30

1.05

1.14

1.10

0.81

EV/Core EBITDA(x)

-10.68

-36.31

14.58

10.30

-38.47

EV/EBIT(x)

-8.96

-25.50

17.74

14.92

-19.37

EV/CE(x)

1.40

1.23

1.63

0.77

0.60

M Cap / Sales

1.14

0.87

1.14

1.11

0.78

Growth Ratio

Net Sales Growth(%)

-26.29

-18.27

9.86

24.34

-5.61

Core EBITDA Growth(%)

-210.38

-130.13

-19.25

727.79

-121.58

EBIT Growth(%)

-159.97

-152.21

-3.92

318.25

-149.92

PAT Growth(%)

-92.81

-239.67

7.83

166.65

-316.24

EPS Growth(%)

-92.81

-239.67

7.83

159.70

-287.61

Financial Stability Ratios

Total Debt/Equity(x)

0.25

0.31

0.22

0.17

0.35

Current Ratio(x)

1.21

1.39

1.52

1.51

1.57

Quick Ratio(x)

0.71

0.75

0.88

0.84

0.81

Interest Cover(x)

-2.64

-1.18

2.84

2.55

-0.86

Total Debt/Mcap(x)

0.16

0.23

0.11

0.09

0.26